Effect of receptor phosphorylation on the binding between IRS‐1 and IGF‐1R as revealed by surface plasmon resonance biosensor
暂无分享,去创建一个
Mengsu Yang | M. Wong | M Huang | W P Lai | M S Wong | M Yang | W. Lai | Ming-hui Huang
[1] D. Altschuh,et al. Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance. , 1992, Immunology letters.
[2] C. Fong,et al. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins. , 1999, Biochimica et biophysica acta.
[3] M. Jansson,et al. Characterization of Ligand Binding of a Soluble Human Insulin-like Growth Factor I Receptor Variant Suggests a Ligand-induced Conformational Change* , 1997, The Journal of Biological Chemistry.
[4] D. O'Shannessy,et al. Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction. , 1992, Analytical biochemistry.
[5] D. Leroith,et al. The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis (*) , 1995, The Journal of Biological Chemistry.
[6] P. Cuatrecasas,et al. Monoclonal antibodies to receptors for insulin and somatomedin-C. , 1983, The Journal of biological chemistry.
[7] C. Kahn,et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.
[8] J. Olefsky,et al. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. , 1994, The Journal of biological chemistry.
[9] E. Van Obberghen,et al. Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591786 (*) , 1996, The Journal of Biological Chemistry.
[10] T. Kirchhausen,et al. Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2 , 1995, Current Biology.
[11] B. R. Dey,et al. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. , 1996, Molecular endocrinology.
[12] D. Leroith. Editorial: Insulin-Like Growth Factor I Receptor Signaling-Overlapping or Redundant Pathways? , 2000, Endocrinology.
[13] Magnus Malmqvist,et al. Biospecific interaction analysis using biosensor technology , 1993, Nature.
[14] G. Lienhard,et al. The 60-kDa Phosphotyrosine Protein in Insulin-treated Adipocytes Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.
[15] M. Jansson,et al. Binding affinities of insulin‐like growth factor‐I (IGF‐I) fusion proteins to IGF binding protein 1 and IGF‐I receptor are not correlated with mitogenic activity , 1997, FEBS letters.
[16] C. Roberts,et al. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). , 1993, The Journal of biological chemistry.
[17] G. Lienhard,et al. A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.
[18] M. White,et al. The IRS-1 signaling system. , 1994, Trends in biochemical sciences.
[19] E. Van Obberghen,et al. Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system. , 1996, Endocrinology.
[20] M. Kasuga,et al. A biosensor approach to probe the structure and function of the p85 alpha subunit of the phosphatidylinositol 3-kinase complex. , 1993, The Journal of biological chemistry.
[21] T. O’Neill,et al. Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor (*) , 1995, The Journal of Biological Chemistry.
[22] R. Karlsson,et al. Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors. , 1994, Analytical biochemistry.
[23] Y. Umezawa,et al. An SPR-based screening method for agonist selectivity for insulin signaling pathways based on the binding of phosphotyrosine to its specific binding protein. , 2000, Analytical chemistry.
[24] C T Roberts,et al. Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.
[25] G. Magnusson,et al. Lactose repressor-operator DNA interactions: kinetic analysis by a surface plasmon resonance biosensor. , 1993, Analytical biochemistry.
[26] R. Karlsson,et al. Detection of antigen—antibody interactions by surface plasmon resonance. Application to Epitope Mapping , 1990, Journal of molecular recognition : JMR.
[27] Ling-mei Wang,et al. Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.
[28] C. Kahn,et al. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells , 1985, Nature.
[29] B. Persson,et al. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins , 1991 .
[30] William Arbuthnot Sir Lane,et al. Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.
[31] E. Van Obberghen,et al. Evidence for a Differential Interaction of SHC and the Insulin Receptor Substrate-1 (IRS-1) with the Insulin-like Growth Factor-I (IGF-I) Receptor in the Yeast Two-hybrid System (*) , 1995, The Journal of Biological Chemistry.
[32] A. Ullrich,et al. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. , 1992, The Journal of biological chemistry.